April 20, 2021
Article
A marker that triggers T cells to fight an infection in the gut was found in small numbers in those with a SARS-CoV-2 infection.
The SAA biomarker could allow physicians the opportunity to better care for and manage a patient’s course of disease.
The committee stressed that the events are exceedingly rare, and that the vaccine's benefits outweigh the potential risks.
The Centers for Disease Control and Prevention (CDC) announced that doing so offers very little in terms of protecting against transmission of the airborne virus.
The prevalence of this disease in this patient population is much higher than in the general public.
April 19, 2021
Investigators incorporated universal HIV screening into COVID-19 testing at a Chicago hospital emergency department (ED).
Throughout the study, the investigators noted that no child showed clinical signs of respiratory distress.
Vaccine rollout in Germany intensifies as more doses are delivered to the country.
Video
A cardiology expert discusses the unique and currently investigated relationship between COVID-19, adenovirus vaccines, and thrombotic events.
Ongoing education and proven outcomes need to aid this form of testing.
